AstraZeneca PLC is 149.0x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($286.27 B vs $1.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OCUL | AZN |
|---|---|---|
| Market cap | $1.92 B | $286.27 B |
| US-listed rank | #2135 | #47 |
| Revenue (latest FY) | $51.95M | - |
| Net income (latest FY) | -$265.94M | - |
| Net margin | -511.9% | - |
| SEC filings | 827 | 1,004 |
AstraZeneca PLC is 149.0x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($286.27 B vs $1.92 B).
Full pages: OCULAR THERAPEUTIX, INC and AstraZeneca PLC, or browse the full rankings.